The amino-terminal region of insulin-like growth factor binding protein-3, 1-95IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 293, Issue 1, 2002, Pages 55-60

  Bernard, Laurence ^a   Babajko, Sylvie ^a   Binoux, Michel ^a   Ricort, Jean Marc ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

1 95IGFBP 3; Apoptosis; IGFBP 3; MCF 7 breast carcinoma cells

Indexed keywords

COMPLEMENTARY DNA; HISTONE; SOMATOMEDIN BINDING PROTEIN 3;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL STRAIN MCF 7; CELL STRUCTURE; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ADENOCARCINOMA; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GLYCOSYLATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; VECTORS;

EID: 0036298526     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00181-X     Document Type: Article

References (25)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. IGFs and cell growth
3. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the "150 K" complex during pregnancy
4. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma
5. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
6. Autocrine regulation of cell proliferation by the IGF and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)
7. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF binding protein-3 production and proteolysis in human osteosarcoma cells
8. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effect of IGF-I and insulin
9. Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity
10. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene
11. The role of the insulin-like growth factor system in human cancer
12. Demonstration of receptors for insulin-like growth factor binding protein-3 on HS578T human breast cancer cells
13. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
14. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
15. The type V tranforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
16. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: An alternative mechanism in the regulation of IGF action
17. Insulin-like growth factor-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
18. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis
19. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
20. Insulin-like growth factor binding protein-3 (IGFBP-3) mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells
21. The role of glycosylation in the action of IGFBP-3
22. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay
23. Hyperglycosylation of eosinophil ribonucleases in a promyelocytic leukemia cell line and in differentiated peripheral blood progenitor cells
24. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma
25. Glycoprotein glycosylation and cancer progression